Pyruvate Dehydrogenase structure
|
Common Name | Pyruvate Dehydrogenase | ||
|---|---|---|---|---|
| CAS Number | 9014-20-4 | Molecular Weight | 297.305 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 508.4±50.0 °C at 760 mmHg | |
| Molecular Formula | C17H15NO4 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 261.3±30.1 °C | |
| Name | Pyruvate Dehydrogenase |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 508.4±50.0 °C at 760 mmHg |
| Molecular Formula | C17H15NO4 |
| Molecular Weight | 297.305 |
| Flash Point | 261.3±30.1 °C |
| Exact Mass | 297.100098 |
| LogP | 3.66 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.611 |
| Storage condition | -20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Risk Phrases | 23-24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Alternating sites reactivity is a common feature of thiamin diphosphate-dependent enzymes as evidenced by isothermal titration calorimetry studies of substrate binding.
Biochemistry 52(15) , 2505-7, (2013) Thiamin diphosphate (ThDP)-dependent enzymes play vital roles in cellular metabolism in all kingdoms of life. In previous kinetic and structural studies, a communication between the active centers in ... |
|
|
Enhanced glucose metabolism is preserved in cultured primary myotubes from obese donors in response to exercise training.
J. Clin. Endocrinol. Metab. 98(9) , 3739-47, (2013) It was suggested that human cultured primary myotubes retain the metabolic characteristics of their donor in vitro.The aim of the present study was to investigate whether the metabolic responses to en... |
|
|
Intermittent-relapsing pyruvate dehydrogenase complex deficiency: a case with clinical, biochemical, and neuroradiological reversibility.
Dev. Med. Child Neurol. 54(5) , 472-6, (2012) Pyruvate dehydrogenase complex (PDHC) deficiency causes encephalomyopathies, of which there are four major categories: (1) neonatal encephalopathy with lactic acidosis; (2) an early infantile form, wh... |
| 6-(3-Methoxyphenyl)-6,7-dihydro[1,3]dioxolo[4,5-g]quinolin-8(5H)-one |
| 1,3-Dioxolo[4,5-g]quinolin-8(5H)-one, 6,7-dihydro-6-(3-methoxyphenyl)- |